Latest News

The report highlights how a targeted, mechanism-based approach helped manage a rare and complex form of obesity that developed after severe brain injury in infancy.

Novanta plans to finance the acquisition using a combination of cash on hand, proceeds from a recently completed US$300 million equity raise, and its existing credit facilities.

Anaphylaxis occurs when the immune system overreacts to a substance it perceives as harmful, triggering symptoms that can rapidly become life-threatening.

The agreement was formalised during a signing ceremony held at ADCAN Pharma’s advanced manufacturing facility in Abu Dhabi, bringing together senior leadership from both organisations and key healthcare stakeholders.

The approval allows the company to market the medicine across all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway, subject to national pricing, reimbursement, and market-access requirements.

The Department of Health has begun distributing the injectable through an initial network of 360 health facilities located in high-burden districts.

The Hatfield facility, located north of London, will undergo a phased upgrade that will significantly expand its manufacturing, packaging and distribution capabilities.

The hospital met all required standards set by the Saudi Patient Safety Center, reflecting strong compliance with structured safety protocols and system-wide quality controls across its clinical and operational departments.

Neurodiversity remains a central focus, particularly in identifying autism and ADHD in girls, women, and high-achieving adults who often mask symptoms for years before receiving support.

The project includes a specialised training academy designed to develop advanced skills in biotechnology, quality control, and vaccine production, ensuring a steady pipeline of qualified personnel to support long-term operations and sector growth.